Glioblastoma multiforme (GBM) is one of the deadliest cancers characterized by very limited sensitivity to chemo- and/or radiotherapy. The presence of GBM stem-like cells in the tumor might be relevant for GBM treatment resistance

Ceresa, C., Nicolini, G., Semperboni, S., Requardt, H., Le Duc, G., Santini, C., et al. (2014). Synchrotron-based photon activation therapy effect on cisplatin pre-treated human glioma stem cells. ANTICANCER RESEARCH, 34(10), 5351-5355.

Synchrotron-based photon activation therapy effect on cisplatin pre-treated human glioma stem cells

CERESA, CECILIA;NICOLINI, GABRIELLA;SEMPERBONI, SARA;BENTIVEGNA, ANGELA;DALPRA', LEDA;CAVALETTI, GUIDO ANGELO;Bravin, A.
2014

Abstract

Glioblastoma multiforme (GBM) is one of the deadliest cancers characterized by very limited sensitivity to chemo- and/or radiotherapy. The presence of GBM stem-like cells in the tumor might be relevant for GBM treatment resistance
Articolo in rivista - Articolo scientifico
Synchrotron radiation; cisplatin; glioma stem-like cells; radiochemotherapy
English
2014
34
10
5351
5355
none
Ceresa, C., Nicolini, G., Semperboni, S., Requardt, H., Le Duc, G., Santini, C., et al. (2014). Synchrotron-based photon activation therapy effect on cisplatin pre-treated human glioma stem cells. ANTICANCER RESEARCH, 34(10), 5351-5355.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/55633
Citazioni
  • Scopus 10
  • ???jsp.display-item.citation.isi??? 9
Social impact